12-112022267-G-A
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_006817.4(ERP29):c.401G>A(p.Gly134Glu) variant causes a missense change. The variant allele was found at a frequency of 0.000000685 in 1,460,772 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006817.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ERP29 | NM_006817.4 | c.401G>A | p.Gly134Glu | missense_variant | Exon 3 of 3 | ENST00000261735.4 | NP_006808.1 | |
ERP29 | NM_001034025.2 | c.*100G>A | 3_prime_UTR_variant | Exon 2 of 2 | NP_001029197.1 | |||
LOC124903021 | XR_007063464.1 | n.-117C>T | upstream_gene_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ERP29 | ENST00000261735.4 | c.401G>A | p.Gly134Glu | missense_variant | Exon 3 of 3 | 1 | NM_006817.4 | ENSP00000261735.3 | ||
ERP29 | ENST00000546477.1 | c.98G>A | p.Gly33Glu | missense_variant | Exon 3 of 3 | 3 | ENSP00000449018.1 | |||
ERP29 | ENST00000455836.1 | c.*100G>A | 3_prime_UTR_variant | Exon 2 of 2 | 2 | ENSP00000412083.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1460772Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 726658 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.401G>A (p.G134E) alteration is located in exon 3 (coding exon 3) of the ERP29 gene. This alteration results from a G to A substitution at nucleotide position 401, causing the glycine (G) at amino acid position 134 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at